The global DNA diagnostics market is on an impressive growth trajectory, with sales projected to reach USD 27,094.2 million in 2024, and further expanding to USD 57,420.1 million by 2034. This surge ...

GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, announced today an indication ...

One of the primary obstacles in microarray-based cancer classification is the disproportionate number of features relative to patient samples, leading to model overfitting and reduced accuracy.

We have technologies to generate ‘designer’ and ‘beam search’ arrays from particular glycoconjugates to characterise novel recognition systems. We interpret and display the microarray results using ...

You may have a blood glucose test in a doctor’s office, laboratory, or with a fingerstick meter at home. These tests can help diagnose diabetes or other health concerns and aid in adjusting your ...

Rates of genetic testing for autism and intellectual and development disorders were associated with race, gender, and insurance company.

Apart from their use as a tool for diagnostic testing in a broad sense, microarrays have also become a means for molecule production. For real diagnostics, data interpretation is frequently the ...

New postpartum depression findings could lead to a blood test to identify women at risk and possibly even to a preventive treatment. New postpartum depression research from the University of ...

The multiplexed, fully automated planar microarray platform enables syndromic testing for complex conditions. This intuitive platform offers high throughput with continuous random access ...

Microarray analysis identifies more chromosome abnormalities than traditional karyotyping in prenatal testing. Microarrays will also identify findings of unclear clinical significance that should ...